Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

Similar articles for PubMed (Select 23447025)

1.

Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

Muramatsu S, Tanaka S, Mogushi K, Adikrisna R, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Nakayama K, Tanaka H, Yamaoka S, Arii S.

Hepatology. 2013 Jul;58(1):218-28. doi: 10.1002/hep.26345. Epub 2013 May 27.

PMID:
23447025
2.

EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.

Terris B, Cavard C, Perret C.

J Hepatol. 2010 Feb;52(2):280-1. doi: 10.1016/j.jhep.2009.10.026. Epub 2009 Nov 10.

3.

Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W, Welling TH.

Gastroenterology. 2014 Dec;147(6):1393-404. doi: 10.1053/j.gastro.2014.08.039. Epub 2014 Aug 30.

PMID:
25181692
4.

Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.

Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, Kaneko S.

Hepatology. 2013 Apr;57(4):1484-97. doi: 10.1002/hep.26168. Epub 2013 Jan 18.

PMID:
23174907
5.

OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.

Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang L, Yan HX, Fu J, Chen Y, Zhang HL, Tang L, Zheng LY, He YQ, Li YQ, Wu FQ, Zou SS, Li Z, Wu MC, Feng GS, Wang HY.

J Hepatol. 2012 Sep;57(3):613-20. doi: 10.1016/j.jhep.2012.04.024. Epub 2012 May 19.

PMID:
22612999
6.

Gene expression profiling of liver cancer stem cells by RNA-sequencing.

Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC, Lau J, Wan T, Wang X, Yan Z, Liu H, Zhang Y, Fan ST.

PLoS One. 2012;7(5):e37159. doi: 10.1371/journal.pone.0037159. Epub 2012 May 14.

7.

Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.

Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, Kong G, Kang KS, Nam JS.

J Hepatol. 2011 Jan;54(1):122-31. doi: 10.1016/j.jhep.2010.06.026. Epub 2010 Aug 26.

PMID:
20952084
8.

DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.

Xu X, Liu RF, Zhang X, Huang LY, Chen F, Fei QL, Han ZG.

Mol Cancer Ther. 2012 Mar;11(3):629-38. doi: 10.1158/1535-7163.MCT-11-0531. Epub 2012 Jan 11.

9.

Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.

Liu WT, Jing YY, Yu GF, Han ZP, Yu DD, Fan QM, Ye F, Li R, Gao L, Zhao QD, Wu MC, Wei LX.

Cancer Lett. 2015 Mar 28;358(2):136-43. doi: 10.1016/j.canlet.2014.12.019. Epub 2014 Dec 12.

PMID:
25511737
10.

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW.

Gastroenterology. 2009 Mar;136(3):1012-24. doi: 10.1053/j.gastro.2008.12.004. Epub 2008 Dec 6.

11.

p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.

Qian YW, Chen Y, Yang W, Fu J, Cao J, Ren YB, Zhu JJ, Su B, Luo T, Zhao XF, Dai RY, Li JJ, Sun W, Wu MC, Feng GS, Wang HY.

Gastroenterology. 2012 Jun;142(7):1547-58.e14. doi: 10.1053/j.gastro.2012.02.042. Epub 2012 Feb 28.

PMID:
22387393
12.

Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.

Cheung PF, Cheng CK, Wong NC, Ho JC, Yip CW, Lui VC, Cheung AN, Fan ST, Cheung ST.

PLoS One. 2011;6(12):e28246. doi: 10.1371/journal.pone.0028246. Epub 2011 Dec 16.

13.

G protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinoma.

Yan M, Li H, Zhu M, Zhao F, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li J.

PLoS One. 2013 Apr 10;8(4):e61056. doi: 10.1371/journal.pone.0061056. Print 2013.

14.

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.

Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI.

Breast Cancer Res. 2010;12(6):R94. doi: 10.1186/bcr2773. Epub 2010 Nov 10.

15.

Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY.

Gastroenterology. 2007 Jun;132(7):2542-56. Epub 2007 Apr 15.

PMID:
17570225
16.

Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.

Zhang KZ, Zhang QB, Zhang QB, Sun HC, Ao JY, Chai ZT, Zhu XD, Lu L, Zhang YY, Bu Y, Kong LQ, Tang ZY.

J Hematol Oncol. 2014 Mar 30;7:28. doi: 10.1186/1756-8722-7-28.

17.

Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH, Wei LX.

Cancer Lett. 2014 Oct 1;352(2):160-8. doi: 10.1016/j.canlet.2014.05.008. Epub 2014 Jun 2.

PMID:
24892648
18.

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.

19.

Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.

Liu S, Li N, Yu X, Xiao X, Cheng K, Hu J, Wang J, Zhang D, Cheng S, Liu S.

Gastroenterology. 2013 May;144(5):1031-1041.e10. doi: 10.1053/j.gastro.2013.01.046. Epub 2013 Jan 31.

PMID:
23376424
20.

Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.

Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, Tani T, Zen Y, Kaneko S.

Cancer Res. 2010 Jun 1;70(11):4687-97. doi: 10.1158/0008-5472.CAN-09-4210. Epub 2010 May 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk